Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (VGSCs) are essential transmembrane proteins that mediate the rapid influx of sodium ions required for the initiation and propagation of action potentials in excitable cells, including neurons and skeletal muscle fibers (Catterall, 2012). The tetrodotoxin-sensitive (TTX-S) subtypes—comprising NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6, and NaV1.7—are distinguished by their high affinity for the potent neurotoxin tetrodotoxin, which inhibits ion conductance (de Lera Ruiz & Kraus, 2015). These channels are critical for diverse physiological functions such as sensory signaling, motor coordination, and cognitive processes. Mutations in the genes encoding TTX-S channels (e.g., SCN1A, SCN9A) are linked to a spectrum of disorders known as channelopathies, including various forms of epilepsy, chronic pain syndromes like erythromelalgia, and muscle disorders like periodic paralysis (StatPearls, 2023). Pharmacologically, these channels are the primary targets for local anesthetics, antiarrhythmics, and anticonvulsants, which act by blocking the pore or modulating gating kinetics to suppress pathological hyperexcitability (PubMed, 2023).
Inhibition of sodium ion influx through the channel pore, typically via state-dependent binding to the alpha subunit, which stabilizes the inactivated state and prevents repetitive firing (Catterall, 2012; StatPearls, 2023).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel, tetrodotoxin-sensitive subtype (TTX-S VGSC) (TTX-S VGSC).